1 |
Yang L, Zhang F, Yan Y, Gu X, Zhou S, Su X, Ji B, Zhong H, Dong C. A Comprehensive Analysis to Elucidate the Effects of Spraying Mineral Elements on the Accumulation of Flavonoids in Epimedium sagittatum during the Harvesting Period. Metabolites 2023;13. [PMID: 36837913 DOI: 10.3390/metabo13020294] [Reference Citation Analysis]
|
2 |
Li Y, Li H, He Q, Yang X. Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review. Molecules 2022;28. [PMID: 36615387 DOI: 10.3390/molecules28010195] [Reference Citation Analysis]
|
3 |
Boyang C, Yuexing L, Yiping Y, Haiyang Y, Lingjie Z, Liancheng G, Xufei Z, Jie Z, Yunzhi C. Mechanism of Epimedium intervention in heart failure based on network pharmacology and molecular docking technology. Medicine (Baltimore) 2022;101:e32059. [PMID: 36451478 DOI: 10.1097/MD.0000000000032059] [Reference Citation Analysis]
|
4 |
Liu M, Hu T, Gou W, Chang H, Li Y, Li Y, Zuo D, Hou W, Jiao S. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation. Front Pharmacol 2022;13:993022. [PMID: 36467051 DOI: 10.3389/fphar.2022.993022] [Reference Citation Analysis]
|
5 |
Yang L, Zhou S, Hou Y, Ji B, Pei L, Su X, Zhong H, Dong C. Blue light induces biosynthesis of flavonoids in Epimedium sagittatum (Sieb.et Zucc.) Maxim. leaves, a study on a light-demanding medicinal shade herb. Industrial Crops and Products 2022;187:115512. [DOI: 10.1016/j.indcrop.2022.115512] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Guven DC, Sahin TK, Rizzo A, Ricci AD, Aksoy S, Sahin K. The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges. Applied Sciences 2022;12:10548. [DOI: 10.3390/app122010548] [Reference Citation Analysis]
|
7 |
Kang J, Zheng Z, Li X, Huang T, Rong D, Liu X, Qin M, Wang Y, Kong X, Song J, Lv C, Pan X. Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma. Cancer Cell Int 2022;22:312. [PMID: 36224624 DOI: 10.1186/s12935-022-02735-3] [Reference Citation Analysis]
|
8 |
Liu K, Sun Q, Liu Q, Li H, Zhang W, Sun C. Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy. Biomedicine & Pharmacotherapy 2022;154:113618. [DOI: 10.1016/j.biopha.2022.113618] [Reference Citation Analysis]
|
9 |
Pu Q, Yu L, Wang X, Yan H, Xie Y, Jiang Y, Yang Z. Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis. J Cancer 2022;13:3280-96. [PMID: 36118529 DOI: 10.7150/jca.74829] [Reference Citation Analysis]
|
10 |
Verzella D, Cornice J, Arboretto P, Vecchiotti D, Di Vito Nolfi M, Capece D, Zazzeroni F, Franzoso G. The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target. Biomedicines 2022;10. [PMID: 36140335 DOI: 10.3390/biomedicines10092233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
11 |
Zhang C, Wang X, Zhang C. Icaritin inhibits CDK2 expression and activity to interfere with tumor progression. iScience 2022;25:104991. [DOI: 10.1016/j.isci.2022.104991] [Reference Citation Analysis]
|
12 |
Zheng H, Liu Q, Wang S, Liu X, Ma M, Shen T, Wang X, Ren D. Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated paraptosis accompanied by autophagosome accumulation. Chem Biol Interact 2022;:110125. [PMID: 36027945 DOI: 10.1016/j.cbi.2022.110125] [Reference Citation Analysis]
|
13 |
Dongye Z, Wu X, Wen Y, Ding X, Wang C, Zhao T, Li J, Wu Y. Icaritin and intratumoral injection of CpG treatment synergistically promote T cell infiltration and antitumor immune response in mice. Int Immunopharmacol 2022;111:109093. [PMID: 35930912 DOI: 10.1016/j.intimp.2022.109093] [Reference Citation Analysis]
|
14 |
Sun Z, Li Y, Gu X, Wang L, Yu B, Yang X, Xu H. Development of icariside II loaded polymeric micelles and evaluation of anticancer activity in vitro and in vivo. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103652] [Reference Citation Analysis]
|
15 |
Li K, Xiao K, Zhu S, Wang Y, Wang W. Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges. Front Pharmacol 2022;13:889799. [DOI: 10.3389/fphar.2022.889799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Ji X, Liu K, Li Q, Shen Q, Han F, Ye Q, Zheng C. A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment. Front Pharmacol 2022;13:851589. [DOI: 10.3389/fphar.2022.851589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
17 |
Tu S, Mao D, Shi M, Zhang H, Liu C, Li X, Zhao Y, Chen Y, Liu Y. Icaritin ameliorates extracellular microparticles‐induced inflammatory pre‐metastatic niche via modulating the cGAS‐STING signaling. Phytotherapy Research. [DOI: 10.1002/ptr.7433] [Reference Citation Analysis]
|
18 |
Zeng Y, Xiong Y, Yang T, Wang Y, Zeng J, Zhou S, Luo Y, Li L. Icariin and its metabolites as potential protective phytochemicals against cardiovascular disease: From effects to molecular mechanisms. Biomedicine & Pharmacotherapy 2022;147:112642. [DOI: 10.1016/j.biopha.2022.112642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
19 |
Zhang J, Xiong W, Wen Y, Fu X, Lu X, Zhang G, Wang C. Magnesium dicarboxylates promote the prenylation of phenolics that is extended to the total synthesis of icaritin. Org Biomol Chem 2022;20:1117-24. [PMID: 35040468 DOI: 10.1039/d1ob02228h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
20 |
Lee J, Han Y, Wang W, Jo H, Kim H, Kim S, Yang KM, Kim SJ, Dhanasekaran DN, Song YS. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Biomolecules 2021;11:1107. [PMID: 34439774 DOI: 10.3390/biom11081107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
21 |
Luo XY, Wu KM, He XX. Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. J Exp Clin Cancer Res 2021;40:172. [PMID: 34006331 DOI: 10.1186/s13046-021-01968-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
|